Mesoblast Newsroom

Why Mesoblast (MESO) Is Among the Best Australian Stocks to Buy Now?

Yahoo FinanceJan 27 21:03

Bullish Mesoblast Insiders Loaded Up On US$145.4m Of Stock

Yahoo FinanceJan 24 05:57

Mesoblast Limited Completes Strategic Share Placement

TipRanksJan 22 13:48

JPMorgan Chase & Co. Ceases Substantial Holding in Mesoblast Limited

TipRanksJan 22 05:50

Bell Potter Remains a Buy on Mesoblast Limited (MEOBF)

TipRanksJan 21 07:36 · Ratings

Mesoblast Price Target Raised to A$3.90/Share From A$1.40 by Bell Potter

Dow JonesJan 21 05:40 · Ratings

First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative Medicine

PR NewswireJan 17 01:46

Mesoblast Substantial Holding Changes Signal Institutional Strategy Shift

TipRanksJan 16 15:16

Mesoblast Announces Director's Interest Change With New Option Acquisitions

TipRanksJan 16 14:37

Mesoblast Incentivizes Employees With Unquoted Equity Issuance

TipRanksJan 15 15:23

Mesoblast Limited to Quote 7.2 Million New Securities on ASX

TipRanksJan 15 14:48

Mesoblast Secures A$260 Million for Ryoncil Launch

TipRanksJan 14 07:47

Why Is the Mesoblast Share Price Crashing 9% Today?

The Motley FoolJan 14 07:47

Express News | Mesoblast - Placement at a$2.50 per Share

BreakingsJan 14 07:11

Express News | Mesoblast Ltd - Raises a$260 Mln for Ryoncil Commercial Launch

BreakingsJan 14 07:10

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

BenzingaJan 10 23:31

Trading Halt: Halted at 4:00:59 A.m. ET - Trading Halt: Halt News Pending

BenzingaJan 10 17:01

Mesoblast Says JPMorgan Chase Reduces Shareholding

MT NewswiresJan 10 10:21

Mesoblast Requests Trading Halt

MT NewswiresJan 10 07:39

Mesoblast Prepares to Launch FDA-approved Therapy for Pediatric Steroid-Refractory AGVHD | ASX:MSB

Proactive InvestorsJan 10 02:50